1;Cover;1
2;Front matter;4
3;Contents;6
4;Preface;8
5;Sonography of Normal and Abnormal Thyroid and Parathyroid Glands;10
5.1;Abstract;10
5.2;Thyroid Ultrasonography;11
5.3;Parathyroid Ultrasonography;20
5.4;References;23
6;Computed Tomography and Magnetic Resonance Imaging of the Thyroid and Parathyroid Glands;25
6.1;Abstract;25
6.2;Thyroid;25
6.3;Parathyroid;28
6.4;References;31
7;Role of Nuclear Medicine in the Diagnosis of Benign Thyroid Diseases;33
7.1;Abstract;33
7.2;Nuclear Medicine: Radiopharmacology and Methods;34
7.3;Devices;34
7.4;Radiopharmaceuticals;35
7.5;Technetium-99m;35
7.6;Measurement of Technetium Uptake;35
7.7;Iodine Isotopes: 123 I and 131 I;35
7.8;Measurement of Iodine Uptake;36
7.9;Thyroid Scintigraphy;36
7.10;Other Thyroid Examinations and Tests;37
7.11;Benign Thyroid Diseases and Indications for Nuclear Medicine Tests;40
7.12;Acknowledgements;44
7.13;References;44
8;Hybrid Molecular Imaging in Differentiated Thyroid Carcinoma;46
8.1;Abstract;46
8.2;The Use of Radioiodine in Thyroid Carcinomas;47
8.3;Single-Photon Emission Computed Tomography/Computed Tomography in Differentiated Thyroid Carcinoma;49
8.4;Position Emission Tomography/Computed Tomography in Differentiated Thyroid Carcinoma;51
8.5;Conclusions;52
8.6;References;53
9;Endoscopic Ultrasound in Endocrinology: Imaging of the Adrenals and the Endocrine Pancreas;55
9.1;Abstract;55
9.2;Technical Details;56
9.3;Resolution;57
9.4;Indications and Typical Findings;57
9.5;Conclusion;62
9.6;References;62
10;Adrenal Imaging: Magnetic Resonance Imagingand Computed Tomography;64
10.1;Abstract;64
10.2;Introduction;64
10.3;Benign Lesions;70
10.4;Malignant Lesions;73
10.5;Image-Guided Intervention;75
10.6;References;77
11;Adrenal Molecular Imaging;79
11.1;Abstract;79
11.2;Molecular Imaging Techniques;80
11.3;Adrenal Incidentalomas;81
11.4;Molecular Imaging of Adrenal Tumors;82
11.5;Primary Aldosteronism;83
11.6;11 C-Metomidate PET in Adrenocortical Cancer;83
11.7;123 I-Metomidate SPECT;84
11.8;Pheochromocytoma;84
11.9;References;87
12;Gonadal Imaging in Endocrine Disorders;89
12.1;Abstract;89
12.2;Male Gonads;89
12.3;Female Gonads;97
12.4;References;104
13;Magnetic Resonance Imaging of Pituitary Tumors;106
13.1;Abstract;106
13.2;The Normal Pituitary Gland;106
13.3;Pituitary Adenomas;108
13.4;Collision Lesions of the Pituitary Region;120
13.5;The Postoperative Sella;120
13.6;Differential Diagnosis of Sellar Space-Occupying Lesions;123
13.7;References;128
14;Intraoperative Magnetic Resonance Imaging for Pituitary Adenomas;130
14.1;Abstract;130
14.2;Scanners and Setups;131
14.3;Results of Low-Field Studies;133
14.4;Results of High-Field Studies;135
14.5;Use of Neuronavigation;136
14.6;Intraoperative Imaging and Endoscopic Surgery;139
14.7;Conclusions;139
14.8;References;139
15;Molecular Imaging of Pituitary Pathology;142
15.1;Abstract;142
15.2;Receptor Imaging of Pituitary Tumors;143
15.3;Dopamine D2 Receptor Imaging of Pituitary Adenomas;143
15.4;Dopamine D2 Receptor Imaging of Pituitary Carcinomas;143
15.5;Somatostatin Receptor Scintigraphy of Pituitary Disorders;144
15.6;18F-Fluorodeoxy-D-Glucose Positron EmissionTomography and Pituitary Pathology;147
15.7;L - 11 C-Methionine Positron Emission Tomography and Pituitary Pathology;149
15.8;Conclusions;149
15.9;References;149
16;Imaging of Neuroendocrine Tumors;151
16.1;Abstract;151
16.2;Imaging Techniques;152
16.3;Neuroendocrine Tumor Characteristics, Presentationand Image Findings;156
16.4;Imaging in Therapy Monitoring;158
16.5;References;159
17;Author Index;161
18;Subject Index;162
19;Cover;166